Pharmacokinetic profile and behavioral effects of gabapentin in the horse

Journal of Veterinary Pharmacology and Therapeutics

Volumn 33, Issue 5, 2010, Pages 485-494

  Terry, R L ^a   McDonnell, S M ^a   Van Eps, A W ^a   Soma, L R ^a   Liu, Y ^b   Uboh, C E ^b   Moate, P J ^c   Driessen, B ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WEST CHESTER UNIVERSITY   (United States)

^c DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; VETERINARY DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; COMPARTMENT MODEL; CONTROLLED STUDY; DRINKING; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAPHY; GELDING; HEART RATE; HORSE; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SEDATION; STANDING; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

AMINES; ANIMALS; ANTI-ANXIETY AGENTS; CONSCIOUS SEDATION; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HEART RATE; HORSES; MALE;

EQUIDAE;

EID: 77956645107     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2010.01161.x     Document Type: Article

References (39)

1. Akaike, H. (1976) An information criterion (AIC). Mathematical Sciences, 14, 5 9.
2. Arendt-Nielsen, L., Brøndum Frøkjær, J., Staahl, C., Graven-Nielsen, T., Huggins, J.P., Smart, T.S. Mohr-Drewes, A. (2007) Effects of gabapentin on experimental somatic pain and temporal summation. Regional Anesthesia and Pain Medicine, 32, 382 388.
3. Baillie, J.K. Power, I. (2006) The mechanism of action of gabapentin in neuropathic pain. Current Opinion in Investigational Drugs, 7, 33 39.
4. Berry, D.J., Beran, R.G., Plunkeft, M.J., Clarke, L.A. Hung, W.T. (2003) The absorption of gabapentin following high dose escalation. Seizure, 12, 28 36.
5. Beydoun, A., Uthman, B.M. Sackellares, J.C. (1995) Gabapentin: pharmacokinetics, efficacy, and safety. Current Opinion in Investigational Drugs, 7, 33 39.
6. Boyd, R.A., Türck, D., Abel, R.B., Sedman, A.J. Bockbrader, H.N. (1999) Effects of age and gender on single-dose pharmacokinetics of gabapentin. Epilepsia, 40, 474 479.
7. Carlsson, K.C. Reubsaet, J.L.E. (2004) Sample preparation and determination of gabapentin in venous and capillary blood using liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 34, 415 423.
8. Davis, J.L., Posner, L.P. Elce, Y. (2007) Gabapentin for the treatment of neuropathic pain in a pregnant horse. Journal of the American Veterinary Medical Association, 231, 755 758.
9. Del Amoa, E.M., Urtti, A. Yliperttula, M. (2008) Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. European Journal of Pharmaceutical Sciences, 35, 161 174.
10. Dirikolu, L., Dafalla, A., Ely, K.J., Connerly, A.L., Jones, C.N., Elk Holy, H., Lehner, A.F., Thompson, K. Tobin, T. (2008) Pharmacokinetics of gabapentin in horses. Journal of Veterinary Pharmacology and Therapeutics, 31, 175 177.
11. Dutton, D.W., Lashnits, K.J. Wegner, K. (2009) Managing severe hoof pain in a horse using multimodal analgesia and a modified composite pain score. Equine Veterinary Education, 21, 37 43.
12. Eckhardt, K., Ammon, S., Hofmann, U., Riebe, A., Gugeler, N. Mikus, G. (2000) Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesthesia & Analgesia, 91, 185 191.
13. Foldvary-Schaefer, N., De Leon Sanchez, I., Karafa, M., Mascha, E., Dinner, D. Morris, H.H. (2002) Gabapentin increases slow-wave sleep in normal adults. Epilepsia, 43, 1493 1497.
14. Gabrielsson, J. Weiner, D. (2000) Pharmacokinetic and pharmacodynamic data analysis: concepts and applications, 3rd edn, pp. 81 82. Swedish Pharmaceutical Press, Stockholm, Sweden.
15. Gatti, G., Ferrari, A.R., Guerrini, R., Bonanni, P., Bonomi, I. Perucca, E. (2003) Plasma gabapentin concentrations in children with epilepsy: influence of age, relationship with dosage, and preliminary observations on correlation with clinical response. Therapeutic Drug Monitoring, 25, 54 60. (Pubitemid 36139826)
16. 2-Δ subunit of a calcium channel. Journal of Biological Chemistry, 271, 5768 5776.
17. Gidal, B.E., De Cerce, J., Bockbrader, H.N., Gonzalez, J., Kruger, S., Pitterle, M.E., Rutecki, P. Ramsay, R.E. (1998) Gabapentin bioavailability: effect of dose and frequency of administration in adult patients with epilepsy. Epilepsy Research, 31, 91 99.
18. Gidal, B.E., Radulovic, L.L., Kruger, S., Rutecki, P., Pitterle, M. Bockbrader, H.N. (2000) Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability. Epilepsy Research, 40, 123 127.
19. Gilron, I. (2007) Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions. Current Opinion in Anesthesiology, 20, 456 472.
20. Haig, G.M., Bockbrader, H.N., Wesche, D.L., Boellner, S.W., Ouellet, D., Brown, R.R., Randinitis, E.J. Posvar, E.L. (2001) Single-dose gabapentin pharmacokinetics and safety in healthy infants and children. The Journal of Clinical Pharmacology, 41, 507 514. (Pubitemid 32381868)
21. Harding, L.M., Kristensen, J.D. Baranowski, A.P. (2005) Differential effects of neuoropathic analgesics on wind-up-like pain and somatosensory function in healthy volunteers. Clinical Journal of Pain, 21, 127 132.
22. Hubbell, J.A.E. Muir, W.W. (2006) Antagonism of detomidine sedation in the horse using intravenous tolazoline or atipamazole. Equine Veterinary Journal, 38, 238 241.
23. Jensen, A.A., Mosbacher, J., Elg, S., Lingenhoel, K., Lohmann, T., Johansen, T.N., Abrahamsen, B., Mattsson, J.P., Lehmann, A., Bettler, B. Bräuner-Osborne, H. (2002) The anticonvulsant gabapentin (neurontin) does not act through γ-aminobutyric acid-B receptors. Molecular Pharmacology, 61, 1377 1384.
24. Jones, E., Viñuela-Fernandez, I., Eager, R.A., Delaney, A., Anderson, H., Patel, A., Robertson, D.C., Allchorne, A., Sirinathsinghji, E.C., Milne, E.M., Macintyre, N., Shaw, D.J., Waran, N.K., Mayhew, J. Fleetwood-Walker, S.M. (2007) Neuropathic pain changes in equine laminitis pain. Pain, 132, 321 331.
25. Kohn, C.W., Muir, W.W. Sams, R. (1978) Plasma volume and extracellular fluid volume in horses at rest and following exercise. American Journal of Veterinary Research, 39, 871 874.
26. Kong, V.K.F. Irwin, M.G. (2007) Gabapentin: a multimodal perioperative drug? British Journal of Anaesthesia, 99, 775 786.
27. Laird, M.A. Gidal, B.E. (2000) Use of gabapentin in the treatment of neuropathic pain. The Annals of Pharmacotherapy, 34, 802 806.
28. Lehner, A.F., Stewart, J., Dafalla, A., Ely, K.J., Connerly, A.L., Jones, C.N., ElkHoly, H., Thompson, K., Tobin, T. Dirikolu, L. (2007) Gabapentin in horses: validation of an analytical method for gabapentin quantitation. Journal of Analytical Toxicology, 31, 555 565.
29. Luo, Z.D., Chaplan, S.R., Higuera, E.S., Sorkin, L.S., Stauderman, K.A., Williams, M.E. Yaksh, T.L. (2001) Upregulation of dorsal root ganglion α2Δ calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. Journal of Neuroscience, 21, 1868 1875.
30. Maneuf, Y.P., Luo, Z.D. Lee, K. (2006) α2Δ and the mechanism of action of gabapentin in the treatment of pain. Seminars in Cell & Developmental Biology, 17, 565 570.
31. Naylor, J.R., Bayly, W.M., Schott, H.C., Gollnick, P.D. Hodgson, D.R. (1993) Equine plasma and blood volumes decrease with dehydration but subsequently increase with exercise. Journal of Applied Physiology, 75, 1002 1008.
32. Newton, R.A., Bingham, S., Case, P.C., Sanger, G.J. Lawson, S.N. (2001) Dorsal root ganglion neurons show increased expression of the calcium channel α2Δ - 1 subunit following partial sciatic nerve injury. Brain Research Molecular Brain Research, 95, 1 8.
33. Pan, H.L., Eisenach, J.C. Chen, S.R. (1999) Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. Journal of Pharmacology and Experimental Therapeutics, 288, 1026 1030.
34. Radulovic, L.L., Türck, D., von Hodenberg, A., Vollmer, K.O., McNally, W.P., Dehart, P.D., Hanson, B.J., Bockbrader, H.N. Chang, T. (1995) Disposition of gabapentin (Neurontin) in mice, rats, dogs and monkeys. Drug Metabolism and Disposition, 23, 441 448.
35. Stewart, B.H., Kugler, A.R., Thompson, P.R. Bockbrader, H.N. (1993) A saturable transport mechanism in intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharmaceutical Research, 10, 276 281.
36. Taylor, C.P., Gee, N.S., Su, T.Z., Kocsis, J.D., Welty, D.F., Brown, J.P., Dooley, D.J., Boden, P. Singh, L. (1998) A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Research, 29, 233 249.
37. Vollmer, K.O., von Hodenberg, A. Kölle, E.U. (1986) Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Drug Research, 36, 830 839.
38. Vollmer, K.O., Anhut, H., Thomann, P., Wagner, F. Jähnchen, D. (1989) Pharmacokinetic model and absolute bioavailability of the new anticonvulsant gabapentin. Advances in Epileptology, 17, 209 211.
39. Yamaoka, K., Nakagawa, T. Uno, T. (1978) Application of Akaike's information criterion in the evaluation of linear pharmacokinetic equations. European Journal of Pharmaceutics and Biopharmaceutics, 6, 165 175.